SHIGA UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.shiga-u.ac.jp
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Small Cell Lung Cancer
- Interventions
- Biological: HLA-A*2402-restricted CDCA1 and KIF20A peptides
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Shiga University
- Target Recruit Count
- 9
- Registration Number
- NCT01069653
- Locations
- 🇯🇵
Shiga University of Medical Science Hospital, Otsu, Shiga, Japan
Shiga Progression of Diabetes, Nephropathy and Retinopathy
Not Applicable
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2009-02-19
- Lead Sponsor
- Shiga University
- Target Recruit Count
- 400
- Registration Number
- NCT00846716
- Locations
- 🇯🇵
Shiga University of Medical Science, Otsu, Shiga, Japan
Rationale and Design for Shiga Microalbuminuria Reduction Trial
Phase 4
- Conditions
- HypertensionDiabetes MellitusAlbuminuria
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-04-27
- Lead Sponsor
- Shiga University
- Target Recruit Count
- 160
- Registration Number
- NCT00202618
- Locations
- 🇯🇵
Shiga University of Medical Science, Otsu, Shiga, Japan
© Copyright 2025. All Rights Reserved by MedPath